Tyvaso (treprostinil) Treprostinil recalls
The FDA has published 1 recall involving Tyvaso (treprostinil) Treprostinil since 2017. The latest was reported on 29 Nov 2017. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 Nov 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why tyvaso (treprostinil) treprostinil is recalled
Companies
By year
All tyvaso (treprostinil) treprostinil recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tyvaso (treprostinil) Inhalation Solution Treprostinil recalled | United Therapeutics | Manufacturing (CGMP) Deviations | PA |
Should you stop taking Tyvaso (treprostinil) Treprostinil?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.